Mohammad Reza Abbaszadegan
Overview
Explore the profile of Mohammad Reza Abbaszadegan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
180
Citations
1903
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Maharati A, Taghehchian N, Taghavinia F, Golshan A, Aarabi A, Abbaszadegan M, et al.
Biochem Biophys Rep
. 2025 Jan;
40:101843.
PMID: 39886373
Background: Renal cell carcinoma (RCC) is a common urological cancer globally and shows a favorable prognosis in early stages of the tumor progression. Due to the poor prognosis for metastatic...
2.
Yazdi Z, Roshannezhad S, Sharif S, Abbaszadegan M
J Transl Med
. 2024 Dec;
22(1):1173.
PMID: 39741289
Creating fast, non-invasive, precise, and specific diagnostic tests is crucial for enhancing cancer treatment outcomes. Among diagnostic methods, those relying on nucleic acid detection are highly sensitive and specific. Recent...
3.
Morshedzadeh F, Abbaszadegan M, Peymani M, Mozaffari-Jovin S
Funct Integr Genomics
. 2024 Oct;
24(5):183.
PMID: 39367162
In personalized cancer medicine, the identification of KRAS mutations is essential for making treatment decisions and improving patient outcomes. This work presents a comprehensive review of the current approaches for...
4.
Taghavinia F, Akhlaghipour I, Golshan A, Aarabi A, Abbaszadegan M, Moghbeli M
Pathol Res Pract
. 2024 Oct;
263:155630.
PMID: 39353324
Background: Renal cell carcinoma (RCC) is one of the most frequent urological cancers globally that has a good prognosis in the early tumor stages. However, there is a poor prognosis...
5.
Cali E, Quirin T, Rocca C, Efthymiou S, Riva A, Marafi D, et al.
Genet Med
. 2024 Sep;
:101251.
PMID: 39275948
Purpose: This study aims to comprehensively delineate the phenotypic spectrum of ACTL6B-related disorders, previously associated with both autosomal recessive and autosomal dominant neurodevelopmental disorders. Molecularly, the role of the nucleolar...
6.
Khorshid Sokhangouy S, Alizadeh F, Lotfi M, Sharif S, Ashouri A, Yoosefi Y, et al.
Expert Rev Mol Diagn
. 2024 Aug;
24(8):677-702.
PMID: 39132997
Introduction: Colon cancer, ranked as the fourth leading global cause of cancer death, exhibits a complex progression marked by genetic variations. Over the past decade, the utilization of diverse CRISPR...
7.
Tolue Ghasaban F, Ghanei M, Mahmoudian R, Taghehchian N, Abbaszadegan M, Moghbeli M
Heliyon
. 2024 May;
10(9):e30599.
PMID: 38726188
Pancreatic cancer (PC), as one of the main endocrine and digestive systems malignancies has the highest cancer related mortality in the world. Lack of the evident clinical symptoms and appropriate...
8.
Kadhim D, Azari H, Khorshid Sokhangouy S, Hassanian S, Alshekarchi H, Goshayeshi L, et al.
Genes (Basel)
. 2024 Apr;
15(4).
PMID: 38674408
Colorectal cancer (CRC) imposes a significant healthcare burden globally, prompting the quest for innovative biomarkers to enhance diagnostic and therapeutic strategies. This study investigates the GPSM) family across several cancers...
9.
Bani N, Rahmani F, Shakour N, Amerizadeh F, Khalili-Tanha G, Khazaei M, et al.
Anticancer Agents Med Chem
. 2024 Apr;
24(12):916-927.
PMID: 38584531
Background: Colorectal cancer (CRC) remains a significant contributor to mortality, often exacerbated by metastasis and chemoresistance. Novel therapeutic strategies are imperative to enhance current treatments. The dysregulation of the PI3K/Akt...
10.
Lotfi M, Morshedi Rad D, Mashhadi S, Ashouri A, Mojarrad M, Mozaffari-Jovin S, et al.
Stem Cell Rev Rep
. 2023 Sep;
19(8):2576-2596.
PMID: 37723364
Rapid advancement in genome editing technologies has provided new promises for treating neoplasia, cardiovascular, neurodegenerative, and monogenic disorders. Recently, the clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9)...